In last trading session, ORIC Pharmaceuticals Inc (NASDAQ:ORIC) saw 0.46 million shares changing hands with its beta currently measuring 1.21. Company’s recent per share price level of $7.79 trading at $0.09 or 1.17% at ring of the bell on the day assigns it a market valuation of $553.30M. That closing price of ORIC’s stock is at a discount of -97.69% from its 52-week high price of $15.40 and is indicating a premium of 18.74% from its 52-week low price of $6.33. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.51 million shares which gives us an average trading volume of 960.10K if we extend that period to 3-months.
For ORIC Pharmaceuticals Inc (ORIC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.51 in the current quarter.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) trade information
Upright in the green during last session for gaining 1.17%, in the last five days ORIC remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $7.79 price level, adding 3.95% to its value on the day. ORIC Pharmaceuticals Inc’s shares saw a change of -3.47% in year-to-date performance and have moved -2.63% in past 5-day. ORIC Pharmaceuticals Inc (NASDAQ:ORIC) showed a performance of -17.57% in past 30-days. Number of shares sold short was 13.54 million shares which calculate 8.51 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 20 to the stock, which implies a rise of 61.05% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 21. It follows that stock’s current price would jump 10.14% in reaching the projected high whereas dropping to the targeted low would mean a gain of 10.14% for stock’s current value.
ORIC Pharmaceuticals Inc (ORIC) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -15.32% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -10.11% while estimates for its earnings growth in next 5 years are of -5.82%.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC)’s Major holders
Insiders are in possession of 9.44% of company’s total shares while institution are holding 103.74 percent of that, with stock having share float percentage of 114.55%. Investors also watch the number of corporate investors in a company very closely, which is 103.74% institutions for ORIC Pharmaceuticals Inc that are currently holding shares of the company. NEXTECH INVEST LTD. is the top institutional holder at ORIC for having 5.29 million shares of worth $37.37 million. And as of 2024-06-30, it was holding 7.5136 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 4.92 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.3057 of outstanding shares, having a total worth of $34.79 million.
On the other hand, ACAP Strategic Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.92 shares of worth $14.96 million or 2.70% of the total outstanding shares. The later fund manager was in possession of 1.88 shares on Dec 31, 2024 , making its stake of worth around $14.67 million in the company or a holder of 2.65% of company’s stock.
